×
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.78 (-2.03%)
MSFT   258.61 (-2.37%)
META   163.30 (-3.65%)
GOOGL   2,247.51 (-2.99%)
AMZN   108.13 (-4.50%)
TSLA   702.50 (-4.39%)
NVDA   160.95 (-4.59%)
NIO   22.31 (-2.79%)
BABA   116.98 (-1.47%)
AMD   80.96 (-6.04%)
MU   58.61 (-0.29%)
CGC   3.59 (-5.28%)
T   20.66 (-0.58%)
GE   65.85 (-1.29%)
F   11.91 (-1.08%)
DIS   96.96 (+0.36%)
AMC   13.59 (-3.82%)
PFE   50.49 (-2.68%)
PYPL   72.40 (-4.66%)
NFLX   181.53 (-4.02%)
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.78 (-2.03%)
MSFT   258.61 (-2.37%)
META   163.30 (-3.65%)
GOOGL   2,247.51 (-2.99%)
AMZN   108.13 (-4.50%)
TSLA   702.50 (-4.39%)
NVDA   160.95 (-4.59%)
NIO   22.31 (-2.79%)
BABA   116.98 (-1.47%)
AMD   80.96 (-6.04%)
MU   58.61 (-0.29%)
CGC   3.59 (-5.28%)
T   20.66 (-0.58%)
GE   65.85 (-1.29%)
F   11.91 (-1.08%)
DIS   96.96 (+0.36%)
AMC   13.59 (-3.82%)
PFE   50.49 (-2.68%)
PYPL   72.40 (-4.66%)
NFLX   181.53 (-4.02%)
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.78 (-2.03%)
MSFT   258.61 (-2.37%)
META   163.30 (-3.65%)
GOOGL   2,247.51 (-2.99%)
AMZN   108.13 (-4.50%)
TSLA   702.50 (-4.39%)
NVDA   160.95 (-4.59%)
NIO   22.31 (-2.79%)
BABA   116.98 (-1.47%)
AMD   80.96 (-6.04%)
MU   58.61 (-0.29%)
CGC   3.59 (-5.28%)
T   20.66 (-0.58%)
GE   65.85 (-1.29%)
F   11.91 (-1.08%)
DIS   96.96 (+0.36%)
AMC   13.59 (-3.82%)
PFE   50.49 (-2.68%)
PYPL   72.40 (-4.66%)
NFLX   181.53 (-4.02%)
S&P 500   3,844.86 (-1.42%)
DOW   31,139.67 (-0.95%)
QQQ   285.80 (-2.27%)
AAPL   138.78 (-2.03%)
MSFT   258.61 (-2.37%)
META   163.30 (-3.65%)
GOOGL   2,247.51 (-2.99%)
AMZN   108.13 (-4.50%)
TSLA   702.50 (-4.39%)
NVDA   160.95 (-4.59%)
NIO   22.31 (-2.79%)
BABA   116.98 (-1.47%)
AMD   80.96 (-6.04%)
MU   58.61 (-0.29%)
CGC   3.59 (-5.28%)
T   20.66 (-0.58%)
GE   65.85 (-1.29%)
F   11.91 (-1.08%)
DIS   96.96 (+0.36%)
AMC   13.59 (-3.82%)
PFE   50.49 (-2.68%)
PYPL   72.40 (-4.66%)
NFLX   181.53 (-4.02%)
TSE:OPS

Opsens Stock Forecast, Price & News

C$2.36
+0.04 (+1.72%)
(As of 06/28/2022 01:34 PM ET)
Add
Compare
Today's Range
C$2.28
C$2.46
50-Day Range
C$1.63
C$2.35
52-Week Range
C$1.55
C$3.74
Volume
114,910 shs
Average Volume
159,155 shs
Market Capitalization
C$255.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$3.90
30 days | 90 days | 365 days | Advanced Chart

Receive OPS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter.

OPS Stock Forecast (MarketRank)

Overall MarketRank

1.73 out of 5 stars

Analyst Opinion: 3.6Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
Opsens logo

About Opsens (TSE:OPS)

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. The company is headquartered in Québec, Canada.

OPS Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Scientific & Technical Instruments
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
163
Year Founded
N/A

Company Calendar

Last Earnings
4/13/2022
Today
6/28/2022
Next Earnings (Estimated)
7/12/2022

Price Target and Rating

Average Stock Price Forecast
C$3.90
High Stock Price Forecast
C$6.00
Low Stock Price Forecast
C$2.25
Forecasted Upside/Downside
+65.3%
Consensus Rating
Buy
Rating Score (0-4)
3.25
Research Coverage
4 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$33.49 million
Cash Flow
C$0.32 per share
Book Value
C$0.37 per share

Miscellaneous

Free Float
N/A
Market Cap
C$255.61 million
Optionable
Not Optionable
Beta
N/A














Opsens Frequently Asked Questions

Should I buy or sell Opsens stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last year. There are currently 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Opsens stock.
View analyst ratings for Opsens
or view top-rated stocks.

What is Opsens' stock price forecast for 2022?

4 equities research analysts have issued 12-month price objectives for Opsens' stock. Their OPS stock forecasts range from C$2.25 to C$6.00. On average, they expect Opsens' stock price to reach C$3.90 in the next twelve months. This suggests a possible upside of 65.3% from the stock's current price.
View analysts' price targets for Opsens
or view top-rated stocks among Wall Street analysts.

How has Opsens' stock performed in 2022?

Opsens' stock was trading at C$3.10 at the beginning of the year. Since then, OPS stock has decreased by 23.9% and is now trading at C$2.36.
View the best growth stocks for 2022 here
.

When is Opsens' next earnings date?

Opsens is scheduled to release its next quarterly earnings announcement on Tuesday, July 12th 2022.
View our earnings forecast for Opsens
.

How were Opsens' earnings last quarter?

Opsens Inc. (TSE:OPS) issued its earnings results on Wednesday, April, 13th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by $0.01. The company earned $8.10 million during the quarter, compared to analyst estimates of $8.25 million.
View Opsens' earnings history
.

Who are Opsens' key executives?

Opsens' management team includes the following people:
  • Mr. Alan W. Milinazzo, Exec. Chairman (Age 62, Pay $99k)
  • Mr. Louis Laflamme C.A., CPA, CPA, Pres, CEO & Director
  • Mr. Robin Villeneuve C.A., CPA, CFO & Corp. Sec. (Age 55, Pay $267.18k)
  • Mr. Brad Davis, Chief Commercial Officer
  • Mr. Pierre Poulin, Corp. Controller

What other stocks do shareholders of Opsens own?

What is Opsens' stock symbol?

Opsens trades on the Toronto Stock Exchange (TSX) under the ticker symbol "OPS."

How do I buy shares of Opsens?

Shares of OPS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Opsens' stock price today?

One share of OPS stock can currently be purchased for approximately C$2.36.

How much money does Opsens make?

Opsens (TSE:OPS) has a market capitalization of C$255.61 million and generates C$33.49 million in revenue each year.

How many employees does Opsens have?

Opsens employs 163 workers across the globe.

How can I contact Opsens?

The official website for Opsens is opsens.com. The company can be reached via phone at 418-781-0333.

This page (TSE:OPS) was last updated on 6/28/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.